TRCT
NVRO

Tower Research Capital (TRC)’s NEVRO CORP. NVRO Stock Holding History

Tower Research Capital (TRC)’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,131
Closed -$12.4K – 5683
2025
Q1 		$12.4K Sell
2,131
-5,014
-70% -$26.4K ﹤0.01% 3445
2024
Q4 		$26.6K Sell
7,145
-10,667
-60% -$49.2K ﹤0.01% 2973
2024
Q3 		$99.6K Buy
17,812
+6,672
+60% +$46.7K ﹤0.01% 2233
2024
Q2 		$93.8K Buy
11,140
+5,832
+110% +$62.2K ﹤0.01% 2626
2024
Q1 		$76.6K Sell
5,308
-2,776
-34% -$45.9K ﹤0.01% 1989
2023
Q4 		$174K Buy
8,084
+4,922
+156% +$87.8K ﹤0.01% 2211
2023
Q3 		$60.8K Buy
3,162
+668
+27% +$14.2K ﹤0.01% 2381
2023
Q2 		$63.4K Buy
2,494
+1,573
+171% +$45.4K ﹤0.01% 2389
2023
Q1 		$33K Sell
921
-3,253
-78% -$114K ﹤0.01% 2913
2022
Q4 		$165K Buy
4,174
+1,415
+51% +$58.8K 0.01% 1436
2022
Q3 		$128K Sell
2,759
-1,074
-28% -$49.8K ﹤0.01% 2351
2022
Q2 		$168K Buy
3,833
+1,523
+66% +$83.7K ﹤0.01% 1908
2022
Q1 		$167K Sell
2,310
-1,176
-34% -$84.8K ﹤0.01% 1858
2021
Q4 		$283K Buy
3,486
+1,580
+83% +$158K ﹤0.01% 1512
2021
Q3 		$222K Buy
1,906
+1,059
+125% +$139K 0.01% 1722
2021
Q2 		$140K Sell
847
-15,996
-95% -$2.5M ﹤0.01% 2168
2021
Q1 		$2.35M Buy
16,843
+15,406
+1,072% +$2.51M 0.04% 421
2020
Q4 		$249K Sell
1,437
-24,833
-95% -$4.02M 0.01% 1548
2020
Q3 		$3.66M Buy
26,270
+19,892
+312% +$2.66M 0.04% 135
2020
Q2 		$762K Buy
6,378
+6,294
+7,493% +$747K 0.03% 698
2020
Q1 		$8K Sell
84
-22
-21% -$2.65K ﹤0.01% 2138
2019
Q4 		$12K Buy
+106
New +$10.5K ﹤0.01% 2253
2019
Q1 		– Sell
-200
Closed -$8K – 4373
2018
Q4 		$8K Sell
200
-4,141
-95% -$184K ﹤0.01% 2643
2018
Q3 		$248K Buy
4,341
+4,251
+4,723% +$266K 0.02% 853
2018
Q2 		$7K Sell
90
-651
-88% -$54K ﹤0.01% 2972
2018
Q1 		$64K Buy
741
+413
+126% +$33.3K 0.01% 1541
2017
Q4 		$23K Sell
328
-2,892
-90% -$231K ﹤0.01% 1962
2017
Q3 		$293K Buy
+3,220
New +$276K 0.02% 502
2017
Q2 		– Sell
-1,943
Closed -$182K – 3573
2017
Q1 		$182K Buy
1,943
+1,055
+119% +$95.6K 0.02% 300
2016
Q4 		$65K Buy
+888
New +$76K 0.01% 1245
2016
Q3 		– Sell
-1,233
Closed -$91K – 4591
2016
Q2 		$91K Buy
1,233
+1,133
+1,133% +$76.9K 0.01% 1172
2016
Q1 		$6K Hold
100
– – ﹤0.01% 2577
2015
Q4 		$7K Sell
100
-207
-67% -$11.1K ﹤0.01% 2632
2015
Q3 		$14K Buy
307
+230
+299% +$11.1K ﹤0.01% 2048
2015
Q2 		$4K Sell
77
-469
-86% -$23.9K ﹤0.01% 3418
2015
Q1 		$26K Buy
546
+446
+446% +$19.4K ﹤0.01% 2044
2014
Q4 		$4K Buy
+100
New +$3.15K ﹤0.01% 2940

Other funds holding NVRO

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Tower Research Capital (TRC)'s NVRO Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 2,131 shares — an estimated $12.4K sold.

Tower Research Capital (TRC) first reported a position in NVRO in Q4 2014 and held it in 37 quarters. The position peaked at $3.66M in Q3 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Tower Research Capital (TRC) reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,131 NEVRO CORP. shares in Q2 2025, an estimated $12.4K.
  • Tower Research Capital (TRC) first reported a position in NEVRO CORP. in Q4 2014 and held it in 37 quarters.
  • Tower Research Capital (TRC)'s NEVRO CORP. position peaked at $3.66M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.